AVANTI POLAR LIPIDS, INC. Trademark

Trademark Overview


On Thursday, September 26, 2019, a trademark application was filed for AVANTI POLAR LIPIDS, INC. with the United States Patent and Trademark Office. The USPTO has given the AVANTI POLAR LIPIDS, INC. trademark a serial number of 88632780. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Monday, November 7, 2022. This trademark is owned by Avanti Polar Lipids, Inc.. The AVANTI POLAR LIPIDS, INC. trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

cGMP custom manufacture of active agents, additives, or excipients for others; cGMP custom manufacture of lipids for others; custom manufacturing services for others in the field of active agents, additives, or excipients in pharmaceutical preparations; custom manufacturing services for others in the field of lipids; providing information relating to lipids and related compounds for scientific and medical research purposes

Chemical compounds for pharmaceutical or medical use; biometallic compounds for pharmaceutical or medical use; adjuvants for medical use; immunostimulatory compounds for medical use; medical diagnostic reagents; test strips for the detection of bacterial infections for medical use; isotopes for medical use

Chemical compounds for scientific or research use; adjuvants for scientific or research use; chemical reagents for the delivery of lipids for scientific or research use; chemical compounds for use as standards for use with analytical techniques, namely, mass spectrometry; compounds for scientific or research use, namely, lipids, synthetic lipids, polymer modified lipids, lipids with modified head groups, lipids with modified acyl chains, bioactive lipids, fluorescent lipids, isotope labeled lipids, oxidized lipids, sphingolipids, lipid extracts from natural sources, lipids conjugated with modified gold particles; compounds for scientific or research use, namely, fatty acids, glycerolipids, glycerophospholipids, sphingolipids, saccharolipids, sterol lipids, prenol lipids, lipid preparations suitable for protein crystallization, lipid preparations suitable for protein solubilization, detergents, amphiphilic detergents, and antibodies; diagnostic reagents and analytical reagents for scien...

Analytical services, namely, performing nutraceutical testing, NMR analysis, mass spectrometry analysis, infrared spectroscopy analysis, chromatography analysis, gas chromatography analysis, particle size analysis, zeta potential analysis, thin layer chromatography analysis, water content, peroxide oxidation, and phosphorous content analysis, stability testing, and analytical method development and validation; scientific research for medical purposes; analytical services, namely, performing nutraceutical testing, NMR analysis, mass spectrometry analysis, infrared spectroscopy analysis, chromatography analysis, gas chromatography analysis, particle size analysis, zeta potential analysis, thin layer chromatography analysis, water content, peroxide oxidation, and phosphorous content analysis, stability testing, and analytical method development and validation in the field of lipids, nutraceuticals, food products, pharmaceutical products, drug development and commercialization; scientific ...
avanti polar lipids, inc.

General Information


Serial Number88632780
Word MarkAVANTI POLAR LIPIDS, INC.
Filing DateThursday, September 26, 2019
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateMonday, November 7, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicescGMP custom manufacture of active agents, additives, or excipients for others; cGMP custom manufacture of lipids for others; custom manufacturing services for others in the field of active agents, additives, or excipients in pharmaceutical preparations; custom manufacturing services for others in the field of lipids; providing information relating to lipids and related compounds for scientific and medical research purposes
Description of MarkThe mark consists of the word "AVANTI" in a stylized font above the words "POLAR LIPIDS, INC." also in stylized font. The wording appears to the right of the design of a stylized liposome.
Goods and ServicesChemical compounds for pharmaceutical or medical use; biometallic compounds for pharmaceutical or medical use; adjuvants for medical use; immunostimulatory compounds for medical use; medical diagnostic reagents; test strips for the detection of bacterial infections for medical use; isotopes for medical use
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesChemical compounds for scientific or research use; adjuvants for scientific or research use; chemical reagents for the delivery of lipids for scientific or research use; chemical compounds for use as standards for use with analytical techniques, namely, mass spectrometry; compounds for scientific or research use, namely, lipids, synthetic lipids, polymer modified lipids, lipids with modified head groups, lipids with modified acyl chains, bioactive lipids, fluorescent lipids, isotope labeled lipids, oxidized lipids, sphingolipids, lipid extracts from natural sources, lipids conjugated with modified gold particles; compounds for scientific or research use, namely, fatty acids, glycerolipids, glycerophospholipids, sphingolipids, saccharolipids, sterol lipids, prenol lipids, lipid preparations suitable for protein crystallization, lipid preparations suitable for protein solubilization, detergents, amphiphilic detergents, and antibodies; diagnostic reagents and analytical reagents for scientific or research use; formulations comprising lipids for scientific or research use; enzymes for scientific or research use; lipids, chemical additives, and excipients for use in the manufacture of pharmaceutical preparations
Translation of Words in MarkThe English translation of AVANTI in the mark is GO FORWARD.
Disclaimer with Predetermined Text"POLAR LIPIDS, INC."
Goods and ServicesAnalytical services, namely, performing nutraceutical testing, NMR analysis, mass spectrometry analysis, infrared spectroscopy analysis, chromatography analysis, gas chromatography analysis, particle size analysis, zeta potential analysis, thin layer chromatography analysis, water content, peroxide oxidation, and phosphorous content analysis, stability testing, and analytical method development and validation; scientific research for medical purposes; analytical services, namely, performing nutraceutical testing, NMR analysis, mass spectrometry analysis, infrared spectroscopy analysis, chromatography analysis, gas chromatography analysis, particle size analysis, zeta potential analysis, thin layer chromatography analysis, water content, peroxide oxidation, and phosphorous content analysis, stability testing, and analytical method development and validation in the field of lipids, nutraceuticals, food products, pharmaceutical products, drug development and commercialization; scientific research and product development and consultation related thereto in the field of pharmaceuticals and chemicals; scientific research services for others; scientific research services for others in the field of lipids, nutraceuticals, food products, pharmaceutical products, drug development and commercialization; lipidomics services, namely, identification and quantification of lipid compounds in a sample, identification of protein-lipid interactions, and identifying the role of lipids in cellular signaling; cGMP testing services, namely method design, development, qualification and validation, lipid raw material release testing, developing standard operating procedures, quality assurance review, product testing release, and stability testing; formulation services, namely, development and production of liposome and nanoparticle formulations, scaling-up manufacturing processes, and synthesis of lipid compounds for use in formulations, in the field of pharmaceuticals, lipids, and chemicals; providing information relating to chemical characterization, analysis methods, and uses of lipids and related compounds for scientific and medical research purposes

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, October 2, 2019
Primary Code001
First Use Anywhere DateTuesday, May 1, 2001
First Use In Commerce DateTuesday, May 1, 2001

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 2, 2019
Primary Code005
First Use Anywhere DateSunday, September 1, 2002
First Use In Commerce DateSunday, September 1, 2002

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, July 8, 2020
Primary Code040
First Use Anywhere DateWednesday, May 1, 2002
First Use In Commerce DateWednesday, May 1, 2002

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 2, 2019
Primary Code042
First Use Anywhere DateTuesday, May 1, 2001
First Use In Commerce DateTuesday, May 1, 2001

Trademark Owner History


Party NameAVANTI POLAR LIPIDS, LLC
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressALABASTER, AL 35007

Party NameAvanti Polar Lipids, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAlabaster, AL 35007

Trademark Events


Event DateEvent Description
Friday, February 2, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, January 29, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, December 29, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, June 2, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, November 7, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, August 24, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 24, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 24, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 24, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 24, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 21, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, September 20, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, February 25, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, November 4, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 29, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 29, 2020LETTER OF SUSPENSION E-MAILED
Wednesday, July 29, 2020SUSPENSION LETTER WRITTEN
Wednesday, July 8, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 7, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 7, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 8, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 8, 2020NON-FINAL ACTION E-MAILED
Wednesday, January 8, 2020NON-FINAL ACTION WRITTEN
Monday, December 30, 2019ASSIGNED TO EXAMINER
Thursday, October 3, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, October 2, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 30, 2019NEW APPLICATION ENTERED